Skip to content
★ Sign in to follow
LG

Louis Gleckel MD

ProPhase Labs, Inc.
Total declarations
19
Company
1
▲ Purchases (2 ops.)
€277k
▼ Sales (0 ops.)
—

Latest filing published 17 Aug 2020 for ProPhase Labs, Inc., €116k.

Filing timeline

BuySale
Louis Gleckel MD

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Louis Gleckel MD: trading record in brief

Louis Gleckel MD appears in our data through filings on ProPhase Labs, Inc. shares, published by SEC (Form 4). Between 12 July 2010 and 13 August 2020, the trades on record add up to 19 filings.

No open-market sale appears; the market trades are 2 purchases worth €277k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants. Since January 2020: 2 purchases and no sales on the market.

On 17 August 2020 came the latest disclosure, an open-market purchase for €116k in ProPhase Labs, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Louis Gleckel MD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations